Camlin Fine Sciences Board Meeting on Aug 11, 2026 for Q1 FY27 Results
Camlin Fine Sciences Ltd has announced that its Board of Directors will convene on August 11, 2026. The primary agenda item for this meeting is to consider and approve the Un-audited Standalone and Consolidated Financial Results for the first quarter ended June 30, 2026. In line with SEBI regulations, the company also informed about the closure of the trading window for its equity shares, effective from July 1, 2026, until 48 hours after the public announcement of the financial results.
Key Highlights
- Board meeting scheduled for August 11, 2026.
- To approve Q1 FY27 Un-audited Standalone & Consolidated Financial Results.
- Trading window closed from July 1, 2026, until results announcement.
- Compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Price Impact
More from CAMLINFINE
Camlin Fine Sciences Appoints Atul Pradhan as Independent Director
Camlin Fine Sciences Declares Un-audited Financial Results for Q1 FY27
Camlin Fine Q1FY27: consolidated loss widens to ₹33.6 Cr as EBITDA margin falls to 3.4%